$TNGX
Tango Therapeutics, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is TNGX up today? It is at $30.02 (+2.25%), and our scanner flagged it 49 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment TNGX spikes, and full due diligence on TNGX — key stats, earnings, dilution and insider activity. Free.
Get free $TNGX alerts the moment volume spikes
Our scanner flagged $TNGX 49 times in the last 30 days. Create a free account to track $TNGX, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $30.02
- Change today
- +2.25%
- Previous close
- $29.36
- 52-week range
- $6.25 – $34.39
- Market cap
- $4.16B
- Institutional own.
- 99.9%
- Total held
- 100.0%
- Short interest
- 42.7M ▲ +2% vs prior · as of 2026-07-15
- Days to cover
- 15.3d
- Avg daily volume
- 3.2M
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5mthin
- 0.0x
- 15mthin
- 0.0x
- 1hthin
- 0.0x
- 1D
- 0.4x
Get free TNGX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $TNGX up today?
Here is the latest on TNGX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TNGX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystTango Therapeutics Appoints Robert Azelby to Board of DirectorsReported senior commercial leadership roles. He concluded his tenure there as Vice President and General Manager of Oncology, overseeing the commercial performance of Amgen’s $6 billion oncology portfolio. He currently serves on the Boards ofReported deletions occur in 10–15% of all human cancers, including approximately 40% of pancreatic cancer and 15% of lung cancer. Vopimetostat is being evaluated as a monotherapy and in combination clinical studies., from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Smart money in $TNGX
All smart money →- FAFisher Asset Management (Fisher) increased its positionAs of Q2 2026 holdings · filed Aug 4, 2026$18M13F-HR ↗
From SEC 13F quarterly holdings (position as of quarter-end, not a transaction date or price) and dated 13D/13G stake filings. Not investment advice.
Insiders
Insiders buying5 buys, 3 sells last 3 months (12/19 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Crystal Adam Officer | Sold (automatic/other) | -27K 0.02% of company | sold 19% | 116K | $723K at $26.79 | Aug 3, 26 |
Crystal Adam Officer | Other | 27K 0.02% of company | added 23% | 143K | $140K at $5.20 | Aug 3, 26 |
Crystal Adam Officer | Sold (automatic/other) | -27K 0.02% of company | sold 19% | 116K | $792K at $29.34 | Jul 1, 26 |
Crystal Adam Officer | Other | 27K 0.02% of company | added 23% | 143K | $140K at $5.20 | Jul 1, 26 |
Azelby Robert Director | Acquired (grant/award) | +6K | n/a | 6K | n/a | Jun 19, 26 |
Lee Sung Director | Acquired (grant/award) | +570 | added 2.6% | 23K | n/a | Jun 5, 26 |
Rothenberg Mace Director | Acquired (grant/award) | +4K | added 11% | 42K | n/a | Jun 5, 26 |
Calhoun Lesley Ann Director | Acquired (grant/award) | +4K | added 32% | 17K | n/a | Jun 5, 26 |
Ketchum John B Director | Acquired (grant/award) | +4K | added 19% | 25K | n/a | Jun 5, 26 |
Crystal Adam Officer | Sold (automatic/other) | -27K 0.02% of company | sold 19% | 116K | $601K at $22.25 | Jun 1, 26 |
Crystal Adam Officer | Other | 27K 0.02% of company | added 23% | 143K | $140K at $5.20 | Jun 1, 26 |
Gall Matthew Officer | Acquired (grant/award) | +40K 0.03% of company | n/a | 40K | n/a | May 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $TNGX runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- At-the-market (ATM) program — sells new shares into the market gradually over time · About $36M in size
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$TNGX Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$TNGX Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
Stocks similar to TNGX
Comparable names in pharmaceutical preparations, closest in size first.
TNGX stock FAQ
Why is $TNGX up today?
Here is the latest on TNGX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TNGX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the TNGX stock price today?
TNGX last traded at $30.02, up 2.25% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live TNGX alerts?
The TNGX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TNGX 49 times in the last 30 days.
What exchange is TNGX on?
TNGX (Tango Therapeutics, Inc.) trades on XNAS, with a market cap of about $4.16B in the PHARMACEUTICAL PREPARATIONS sector.
Is TNGX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TNGX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.